Synonyms
Definition
Schizophrenia and Other Psychotic Disorders: Psychiatric disorders involving poor understanding or breakdown of reality due to delusions and/or hallucinations.
Introduction
Schizophrenia and other psychotic disorders are commonly characterized by positive symptoms (i.e., delusions and hallucinations) and less so by negative symptoms (i.e., flat affect, anhedonia, and poverty of speech). These disorders are believed to be one of the most severe types of mental illness with significant health-care and economic burdens around the world. In particular, schizophrenia has been labeled as the eighth leading cause of disability in the world (Lopez and Murray 1998). In addition, the annual total costs (including health care, unemployment, and disability needs) associated with schizophrenia in the United States has been estimated to be more than $62 billion (Wu et al. 2005).
Psychotic symptom severity does not necessarily worsen with age in late-life schizophrenic...
References
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Association.
Bankole, A., Cohen, C., Vahia, I., et al. (2008). Symptomatic remission in a multiracial urban population of older adults with schizophrenia. The American Journal of Geriatric Psychiatry, 16, 966–973.
Berry, K., & Barrowclough, C. (2009). The needs of older adults with schizophrenia implications for psychological interventions. Clinical Psychology Review, 29, 68–76.
Cohen, C. I. (1995). Studies of the course and outcome of schizophrenia in later life. Psychiatric Services, 46, 877–879.
Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33, 1225–1237.
Friedman, J. I., Harvey, P. D., Coleman, T., Moriarty, P. J., Bowie, C., Parrella, M., White, L., Adler, D., & Davis, K. L. (2001). Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer’s disease and normal aging. The American Journal of Psychiatry, 158(9), 1441–1448.
Frisoni, G. B., Prestia, A., Adorni, A., Rasser, P. E., Cotelli, M., Soricelli, A., et al. (2009). In vivo neuropathology of cortical changes in elderly persons with schizophrenia. Biological Psychiatry, 66, 578–585.
Granholm, E., Holden, J., Link, P. C., McQuaid, J. R., & Jeste, D. V. (2013). Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: Defeatist performance attitudes and functional outcome. The American Journal of Geriatric Psychiatry, 21(3), 251–262.
Harvey, P. D., Silverman, J. M., Mohs, R. C., et al. (1999). Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry, 45, 32–40.
Howard, R., Rabins, P. V., Seeman, M. V., Jeste, D. V., & International Late-Onset Schizophrenia Group. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. The International Late-Onset Schizophrenia Group. The American Journal of Psychiatry, 157, 172–178.
Jeste, D. V., & Maglione, J. E. (2013). Treating older adults with schizophrenia: Challenges and opportunities. Schizophrenia Bulletin, 39(5), 966–968.
Jeste, D. V., Twamley, E. W., Eyler Zorrilla, L. T., Golshan, S., Patterson, T. L. B., & Palmer, W. (2003). Aging and outcome in schizophrenia. Acta Psychiatrica Scandinavica, 107, 336–343.
Jeste, D. V., Wolkowitz, O. M., & Palmer, B. W. (2011). Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophrenia Bulletin, 37, 451–455.
Lopez, A. D., & Murray, C. C. (1998). The global burden of disease, 1990–2020. Nature Medicine, 4, 1241–1243.
Meesters, P. D., Comijs, H. C., de Haan, L., et al. (2011). Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia. Schizophrenia Research, 126, 237–244.
Meesters, P. D., de Haan, L., Comijs, H. C., Stek, M. L., Smeets-Janssen, M. M., Weeda, M. R., Eikelenboom, P., Smit, J. H., & Beekman, A. T. (2012). Schizophrenia spectrum disorders in later life: Prevalence and distribution of age at onset and sex in a Dutch catchment area. The American Journal of Geriatric Psychiatry, 20, 18–28.
Meesters, P. D., Comijs, H. C., Haan, L., Smit, J. H., Eikelenboom, P., Beekman, A. T. F., & Stek, M. L. (2013). Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients. Schizophrenia Research, 147, 275–280.
National Institute of Mental Health. (2011). Schizophrenia: Statistics. Bethesda: National Institute of Mental Health 2011. Available at: http://www.nimh.nih.gov/statistics/1SCHIZ.shtml.
Palmer, B. W., Dawes, S. E., & Heaton, R. K. (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychology Review, 19, 365–384.
Prestia, A., Cavedo, E., Boccardi, M., Muscio, C., Adorni, A., Geroldi, C., Bonetti, M., Thompson, P. M., & Frisoni, G. B. (2015). Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia. The American Journal of Geriatric Psychiatry, 23, 47–58.
Pridan, S., Swartz, M., Baruch, Y., Tadger, S., Plopski, I., & Barak, Y. (2015). Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. International Psychogeriatrics, 27(1), 131–134.
Ropacki, S. A., & Jeste, D. V. (2005). Epidemiology of and risk factors for psychosis of Alzheimer’s disease: A review of 55 studies published from 1990 to 2003. The American Journal of Psychiatry, 162, 2022–2030.
Saha, S., Chant, D., & McGrath, J. (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64, 1123–1131.
Sigström, R., Skoog, I., Sacuiu, S., Karlsson, B., Klenfeldt, I. F., Waern, M., Gustafson, D., & Östling, S. (2009). The prevalence of psychotic symptoms and paranoid ideation in non-demented population samples aged 70–82 years. International Journal of Geriatric Psychiatry, 24, 1413–1419.
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: A population- based cohort study (FIN11 study). Lancet, 374, 620–627.
Tolman, A. W., & Kurtz, M. M. (2012). Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: A meta-analytic investigation. Schizophrenia Bulletin, 38, 304–315.
Wu, E. Q., Birnbaum, H. G., Shi, L., Ball, D. E., Kessler, R. C., Moulis, M., & Aggarwal, J. (2005). The economic burden of schizophrenia in the United States in 2002. The Journal of Clinical Psychiatry, 66, 1122–1129.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Singapore
About this entry
Cite this entry
Gomez, R., Coopersmith, L. (2015). Schizophrenia and Other Psychotic Disorders in Older Adults. In: Pachana, N. (eds) Encyclopedia of Geropsychology. Springer, Singapore. https://doi.org/10.1007/978-981-287-080-3_271-1
Download citation
DOI: https://doi.org/10.1007/978-981-287-080-3_271-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Online ISBN: 978-981-287-080-3
eBook Packages: Springer Reference Social SciencesReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences